Evidence map›Paper›PMID 42187578›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Emily Trus, Alexander Ruzic, Ram Vasudevan Nampoothiri, Gregory R Pond, Vinita Dhir, Andrew Poskus, Louise Bordeleau, Michael Trus

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emily TrusCollege of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada.
Alexander RuzicDepartment of Graduate Studies, McMaster University, Hamilton, ON L8S 4L8, Canada.
Ram Vasudevan NampoothiriDepartment of Medicine, Transplant and Cellular Therapy Program, Ottawa, ON K1H 8L6, Canada.
Gregory R PondDepartment of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada.ORCID 0000-0003-1033-0882
Vinita DhirDepartment of Medicine, Transplant and Cellular Therapy Program, Ottawa, ON K1H 8L6, Canada.
Andrew PoskusDepartment of Medicine, Transplant and Cellular Therapy Program, Ottawa, ON K1H 8L6, Canada.
Louise BordeleauDepartment of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada.
Michael TrusDepartment of Oncology, McMaster University, Hamilton, ON L8V 5C2, Canada.ORCID 0000-0002-2998-1602

Funding

Jazz Pharmaceuticals (Ireland) IST-20-11273
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseAdolescentAdultAgedCanadaFemaleHumansMaleMiddle AgedPolydeoxyribonucleotidesRisk FactorsTransplantation, HomologousYoung AdultdefibrotidePolydeoxyribonucleotidesallogeneic stem cell transplantsinusoidal obstruction syndrome/veno-occlusive disease

Identifiers

PMID42187578
PMCPMC13205504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.